Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Name: Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Published: 2025
License: Public Domain

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

metastatic pancreatic ductal adenocarcinoma, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Related documents